Clinical Trial Update: Low Dose Statins, Ezetimibe and Nutraceuticals [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on low dose statins, ezetimibe, and nutraceuticals for coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN